Less than two weeks after posting a scathing Form 483 filing, the FDA slammed Chinese API maker Sichuan Deebio Pharmaceuticals with a warning letter (PDF) citing “significant deviations” in its ...

China, the world leader in the API industry, is on a consolidation path and quality drive to raise its own benchmarks in the global turf, that too with no qualms about the tightening quality norms ...

Lonza completed a laboratory expansion project at its API manufacturing facility in Nansha, China. The project, which grew the footprint of the lab by 250 square meters, included the addition of new ...

OpenAI recently surprised users by announcing that, starting July 9, 2024, it will cease providing API services to China and other regions, including Hong Kong. This abrupt decision spells trouble for ...

BEIJING (Reuters) -Chinese artificial intelligence (AI) companies are moving swiftly to attract users of OpenAI's technology, following reports the U.S. firm plans to restrict access in China and ...